| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Delcath Systems Inc (NASDAQ: DCTH)
DCTH Technical Analysis
1.5
| As on 9th Jun 2023 DCTH SHARE Price closed @ 6.95 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.99 & Sell for SHORT-TERM with Stoploss of 7.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DCTHSHARE Price
| Open | 7.23 | Change | Price | % |
| High | 7.23 | 1 Day | -0.05 | -0.71 |
| Low | 6.90 | 1 Week | -1.01 | -12.69 |
| Close | 6.95 | 1 Month | 1.37 | 24.55 |
| Volume | 10513 | 1 Year | -1.25 | -15.24 |
| 52 Week High 8.45 | 52 Week Low 2.59 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DCTH Daily Charts |
DCTH Intraday Charts |
Whats New @ Bazaartrend |
DCTH Free Analysis |
|
|
DCTH Important Levels Intraday
| RESISTANCE | 7.59 |
| RESISTANCE | 7.38 |
| RESISTANCE | 7.26 |
| RESISTANCE | 7.13 |
| SUPPORT | 6.77 |
| SUPPORT | 6.64 |
| SUPPORT | 6.52 |
| SUPPORT | 6.31 |
DCTH Forecast April 2024
| 4th UP Forecast | 9.86 |
| 3rd UP Forecast | 8.93 |
| 2nd UP Forecast | 8.35 |
| 1st UP Forecast | 7.77 |
| 1st DOWN Forecast | 6.13 |
| 2nd DOWN Forecast | 5.55 |
| 3rd DOWN Forecast | 4.97 |
| 4th DOWN Forecast | 4.04 |
DCTH Weekly Forecast
| 4th UP Forecast | 9.17 |
| 3rd UP Forecast | 8.46 |
| 2nd UP Forecast | 8.02 |
| 1st UP Forecast | 7.58 |
| 1st DOWN Forecast | 6.32 |
| 2nd DOWN Forecast | 5.88 |
| 3rd DOWN Forecast | 5.44 |
| 4th DOWN Forecast | 4.73 |
DCTH Forecast2024
| 4th UP Forecast | 18.84 |
| 3rd UP Forecast | 15.03 |
| 2nd UP Forecast | 12.67 |
| 1st UP Forecast | 10.31 |
| 1st DOWN Forecast | 3.59 |
| 2nd DOWN Forecast | 1.23 |
| 3rd DOWN Forecast | -1.13 |
| 4th DOWN Forecast | -4.94 |
Delcath Systems Inc ( NASDAQ USA Symbol : DCTH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DCTH Business Profile
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO includes the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma; and the ALIGN trial, a Phase 3 clinical trial for intrahepatic cholangiocarcinoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Address: 1633 Broadway, New York, NY, United States, 10019
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service